WEST PHARMACEUTICAL SERVICES, INC. Research and Development Expense
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Research and Development Expense of $19.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. research and development expense for the quarter ending 2026-06-30 was $19.70M, a 3.14% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. research and development expense for the quarter ending 2026-03-31 was $15.80M, a 3.07% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. research and development expense for the quarter ending 2025-12-31 was $21.80M, a 17.84% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. research and development expense for the quarter ending 2025-09-30 was $17.10M, a 10.32% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. research and development expense for fiscal 2025 was $74.30M, a 7.53% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. research and development expense for fiscal 2024 was $69.10M, a 1.02% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. research and development expense for fiscal 2023 was $68.40M, a 16.92% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. research and development expense for fiscal 2022 was $58.50M, a 10.80% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.70M 10-Q · filed 2026-07-23 | $35.50M 10-Q · filed 2026-07-23 | $57.30M derived: sum of 3 quarters · filed 2026-07-23 | $74.40M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $15.80M 10-Q · filed 2026-04-23 | $37.60M derived: sum of 2 quarters · filed 2026-04-23 | $54.70M derived: sum of 3 quarters · filed 2026-04-23 | $73.80M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $21.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $38.90M derived: sum of 2 quarters · filed 2026-02-17 | $58.00M derived: sum of 3 quarters · filed 2026-07-23 | $74.30M 10-K · filed 2026-02-17 |
| 2025-09-30 | $17.10M 10-Q · filed 2025-10-23 | $36.20M derived: sum of 2 quarters · filed 2026-07-23 | $52.50M 10-Q · filed 2025-10-23 | $71.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $19.10M 10-Q · filed 2026-07-23 | $35.40M 10-Q · filed 2026-07-23 | $53.90M derived: sum of 3 quarters · filed 2026-07-23 | $69.40M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $16.30M 10-Q · filed 2026-04-23 | $34.80M derived: sum of 2 quarters · filed 2026-04-23 | $50.30M derived: sum of 3 quarters · filed 2026-04-23 | $67.80M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $34.00M derived: sum of 2 quarters · filed 2026-02-17 | $51.50M derived: sum of 3 quarters · filed 2026-02-17 | $69.10M 10-K · filed 2026-02-17 |
| 2024-09-30 | $15.50M 10-Q · filed 2025-10-23 | $33.00M derived: sum of 2 quarters · filed 2025-10-23 | $50.60M 10-Q · filed 2025-10-23 | $69.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $17.50M 10-Q · filed 2025-07-24 | $35.10M 10-Q · filed 2025-07-24 | $53.50M derived: sum of 3 quarters · filed 2026-02-17 | $69.90M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $17.60M 10-Q · filed 2025-04-24 | $36.00M derived: sum of 2 quarters · filed 2026-02-17 | $52.40M derived: sum of 3 quarters · filed 2026-02-17 | $68.90M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $18.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $34.80M derived: sum of 2 quarters · filed 2026-02-17 | $51.30M derived: sum of 3 quarters · filed 2026-02-17 | $68.40M 10-K · filed 2026-02-17 |
| 2023-09-30 | $16.40M 10-Q · filed 2024-10-24 | $32.90M derived: sum of 2 quarters · filed 2024-10-24 | $50.00M 10-Q · filed 2024-10-24 | $65.90M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $16.50M 10-Q · filed 2024-07-25 | $33.60M 10-Q · filed 2024-07-25 | $49.50M derived: sum of 3 quarters · filed 2025-02-18 | $63.10M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $17.10M 10-Q · filed 2024-04-25 | $33.00M derived: sum of 2 quarters · filed 2025-02-18 | $46.60M derived: sum of 3 quarters · filed 2025-02-18 | $61.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $29.50M derived: sum of 2 quarters · filed 2025-02-18 | $43.90M derived: sum of 3 quarters · filed 2025-02-18 | $58.50M 10-K · filed 2025-02-18 |
| 2022-09-30 | $13.60M 10-Q · filed 2023-10-26 | $28.00M derived: sum of 2 quarters · filed 2023-10-26 | $42.60M 10-Q · filed 2023-10-26 | $56.30M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $14.40M 10-Q · filed 2023-07-27 | $29.00M 10-Q · filed 2023-07-27 | $42.70M derived: sum of 3 quarters · filed 2024-02-20 | $55.80M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $14.60M 10-Q · filed 2023-04-27 | $28.30M derived: sum of 2 quarters · filed 2024-02-20 | $41.40M derived: sum of 3 quarters · filed 2024-02-20 | $55.20M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $13.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $26.80M derived: sum of 2 quarters · filed 2024-02-20 | $40.60M derived: sum of 3 quarters · filed 2024-02-20 | $52.80M 10-K · filed 2024-02-20 |
| 2021-09-30 | $13.10M 10-Q · filed 2022-10-27 | $26.90M derived: sum of 2 quarters · filed 2022-10-27 | $39.10M 10-Q · filed 2022-10-27 | $52.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $13.80M 10-Q · filed 2022-07-28 | $26.00M 10-Q · filed 2022-07-28 | $38.90M derived: sum of 3 quarters · filed 2023-02-21 | $51.40M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $12.20M 10-Q · filed 2022-04-28 | $25.10M derived: sum of 2 quarters · filed 2023-02-21 | $37.60M derived: sum of 3 quarters · filed 2023-02-21 | $48.40M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $25.40M derived: sum of 2 quarters · filed 2023-02-21 | $36.20M derived: sum of 3 quarters · filed 2023-02-21 | $46.90M 10-K · filed 2023-02-21 |
| 2020-09-30 | $12.50M 10-Q · filed 2021-10-28 | $23.30M derived: sum of 2 quarters · filed 2021-10-28 | $34.00M 10-Q · filed 2021-10-28 | $44.20M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $10.80M 10-Q · filed 2021-07-30 | $21.50M 10-Q · filed 2021-07-30 | $31.70M derived: sum of 3 quarters · filed 2022-02-22 | $41.00M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $10.70M 10-Q · filed 2021-04-30 | $20.90M derived: sum of 2 quarters · filed 2022-02-22 | $30.20M derived: sum of 3 quarters · filed 2022-02-22 | $39.80M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $19.50M derived: sum of 2 quarters · filed 2022-02-22 | $29.10M derived: sum of 3 quarters · filed 2022-02-22 | $38.90M 10-K · filed 2022-02-22 |
| 2019-09-30 | $9.30M 10-Q · filed 2020-10-23 | $18.90M derived: sum of 2 quarters · filed 2020-10-23 | $28.70M 10-Q · filed 2020-10-23 | $38.50M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $9.60M 10-Q · filed 2020-07-24 | $19.40M 10-Q · filed 2020-07-24 | $29.20M derived: sum of 3 quarters · filed 2021-02-23 | $39.30M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $9.80M 10-Q · filed 2020-04-24 | $19.60M derived: sum of 2 quarters · filed 2021-02-23 | $29.70M derived: sum of 3 quarters · filed 2021-02-23 | $40.50M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $19.90M derived: sum of 2 quarters · filed 2021-02-23 | $30.70M derived: sum of 3 quarters · filed 2021-02-23 | $40.30M 10-K · filed 2021-02-23 |
| 2018-09-30 | $10.10M 10-Q · filed 2019-10-29 | $20.90M derived: sum of 2 quarters · filed 2019-10-29 | $30.50M 10-Q · filed 2019-10-29 | $40.20M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $10.80M 10-Q · filed 2019-07-29 | $20.40M 10-Q · filed 2019-07-29 | $30.10M derived: sum of 3 quarters · filed 2020-02-24 | $39.20M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $9.60M 10-Q · filed 2019-05-08 | $19.30M derived: sum of 2 quarters · filed 2020-02-24 | $28.40M derived: sum of 3 quarters · filed 2020-02-24 | $38.40M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $18.80M derived: sum of 2 quarters · filed 2020-02-24 | $28.80M derived: sum of 3 quarters · filed 2020-02-24 | $39.10M 10-K · filed 2020-02-24 |
| 2017-09-30 | $9.10M 10-Q · filed 2018-10-30 | $19.10M derived: sum of 2 quarters · filed 2018-10-30 | $29.40M 10-Q · filed 2018-10-30 | $39.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $10.00M 10-Q · filed 2018-07-31 | $20.30M 10-Q · filed 2018-07-31 | $29.90M derived: sum of 3 quarters · filed 2019-02-28 | $38.90M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $10.30M 10-Q · filed 2018-05-08 | $19.90M derived: sum of 2 quarters · filed 2019-02-28 | $28.90M derived: sum of 3 quarters · filed 2019-02-28 | $37.70M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $18.60M derived: sum of 2 quarters · filed 2019-02-28 | $27.40M derived: sum of 3 quarters · filed 2019-02-28 | $36.80M 10-K · filed 2019-02-28 |
| 2016-09-30 | $9.00M 10-Q · filed 2017-10-31 | $17.80M derived: sum of 2 quarters · filed 2017-10-31 | $27.20M 10-Q · filed 2017-10-31 | $37.20M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $8.80M 10-Q · filed 2017-08-01 | $18.20M 10-Q · filed 2017-08-01 | $28.20M derived: sum of 3 quarters · filed 2018-02-26 | $36.70M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $9.40M 10-Q · filed 2017-05-05 | $19.40M derived: sum of 2 quarters · filed 2018-02-26 | $27.90M derived: sum of 3 quarters · filed 2018-02-26 | $36.00M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $18.50M derived: sum of 2 quarters · filed 2018-02-26 | $26.60M derived: sum of 3 quarters · filed 2018-02-26 | $34.10M 10-K · filed 2018-02-26 |
| 2015-09-30 | $8.50M 10-Q · filed 2016-10-31 | $16.60M derived: sum of 2 quarters · filed 2016-10-31 | $24.10M 10-Q · filed 2016-10-31 | $31.90M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $8.10M 10-Q · filed 2016-08-01 | $15.60M 10-Q · filed 2016-08-01 | $23.40M derived: sum of 3 quarters · filed 2017-02-28 | $33.00M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $7.50M 10-Q · filed 2016-05-06 | $15.30M derived: sum of 2 quarters · filed 2017-02-28 | $24.90M derived: sum of 3 quarters · filed 2017-02-28 | $34.80M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $17.40M derived: sum of 2 quarters · filed 2017-02-28 | $27.30M derived: sum of 3 quarters · filed 2017-02-28 | $37.30M 10-K · filed 2017-02-28 |
| 2014-09-30 | $9.60M 10-Q · filed 2015-11-02 | $19.50M derived: sum of 2 quarters · filed 2015-11-02 | $29.50M 10-Q · filed 2015-11-02 | $39.20M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $9.90M 10-Q · filed 2015-08-03 | $19.90M 10-Q · filed 2015-08-03 | $29.60M derived: sum of 3 quarters · filed 2016-02-26 | $39.20M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $10.00M 10-Q · filed 2015-05-06 | $19.70M derived: sum of 2 quarters · filed 2016-02-26 | $29.30M derived: sum of 3 quarters · filed 2016-02-26 | $38.80M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $19.30M derived: sum of 2 quarters · filed 2016-02-26 | $28.80M derived: sum of 3 quarters · filed 2016-02-26 | $37.90M 10-K · filed 2016-02-26 |
| 2013-09-30 | $9.60M 10-Q · filed 2014-11-03 | $19.10M derived: sum of 2 quarters · filed 2014-11-03 | $28.20M 10-Q · filed 2014-11-03 | $36.80M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $9.50M 10-Q · filed 2014-08-01 | $18.60M 10-Q · filed 2014-08-01 | $27.20M derived: sum of 3 quarters · filed 2015-02-25 | $35.40M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | $9.10M 10-Q · filed 2014-05-08 | $17.70M derived: sum of 2 quarters · filed 2015-02-25 | $25.90M derived: sum of 3 quarters · filed 2015-02-25 | $34.10M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $16.80M derived: sum of 2 quarters · filed 2015-02-25 | $25.00M derived: sum of 3 quarters · filed 2015-02-25 | $33.20M 10-K · filed 2015-02-25 |
| 2012-09-30 | $8.20M 10-Q · filed 2013-11-04 | $16.40M derived: sum of 2 quarters · filed 2013-11-04 | $24.60M 10-Q · filed 2013-11-04 | $31.90M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $8.20M 10-Q · filed 2013-08-05 | $16.50M 10-Q · filed 2013-08-05 | $23.70M derived: sum of 3 quarters · filed 2014-02-27 | $31.40M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $8.30M 10-Q · filed 2013-05-06 | $15.50M derived: sum of 2 quarters · filed 2014-02-27 | $23.20M derived: sum of 3 quarters · filed 2014-02-27 | $30.50M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $14.90M derived: sum of 2 quarters · filed 2014-02-27 | $22.20M derived: sum of 3 quarters · filed 2014-02-27 | $29.10M 10-K · filed 2014-02-27 |
| 2011-09-30 | $7.70M 10-Q · filed 2012-11-05 | $15.00M derived: sum of 2 quarters · filed 2012-11-05 | $21.90M 10-Q · filed 2012-11-05 | $28.80M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $7.30M 10-Q · filed 2012-08-06 | $14.20M 10-Q · filed 2012-08-06 | $21.10M derived: sum of 3 quarters · filed 2013-02-27 | $27.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $6.90M 10-Q · filed 2012-05-04 | $13.80M derived: sum of 2 quarters · filed 2013-02-27 | $19.70M derived: sum of 3 quarters · filed 2013-02-27 | $25.40M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $12.80M derived: sum of 2 quarters · filed 2013-02-27 | $18.50M derived: sum of 3 quarters · filed 2013-02-27 | $23.90M 10-K · filed 2013-02-27 |
| 2010-09-30 | $5.90M 10-Q · filed 2011-11-07 | $11.60M derived: sum of 2 quarters · filed 2011-11-07 | $17.00M 10-Q · filed 2011-11-07 | $22.80M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-06-30 | $5.70M 10-Q/A · filed 2011-08-08 | $11.10M 10-Q/A · filed 2011-08-08 | $16.90M derived: sum of 3 quarters · filed 2012-03-01 | $22.00M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-03-31 | $5.40M 10-Q · filed 2011-05-05 | $11.20M derived: sum of 2 quarters · filed 2012-03-01 | $16.30M derived: sum of 3 quarters · filed 2012-03-01 | $21.00M derived: sum of 4 quarters · filed 2012-03-01 |
| 2009-12-31 | $5.80M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $10.90M derived: sum of 2 quarters · filed 2012-03-01 | $15.60M derived: sum of 3 quarters · filed 2012-03-01 | $19.90M 10-K/A · filed 2012-03-01 |
| 2009-09-30 | $5.10M 10-Q · filed 2010-11-05 | $9.80M derived: sum of 2 quarters · filed 2010-11-05 | $14.10M 10-Q · filed 2010-11-05 | |
| 2009-06-30 | $4.70M 10-Q · filed 2010-08-05 | $8.90M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | $18.70M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |